MCM2 Antibodies

Santa Cruz Biotechnology delivers a wide array of MCM2 Antibodies for research in cell cycle regulation and DNA replication. MCM2 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MCM2, or Minichromosome Maintenance Protein 2, plays a critical role in the initiation of DNA replication and is essential for maintaining genomic stability. As a key component of the MCM complex, MCM2 is involved in the licensing of DNA replication origins, ensuring that DNA is accurately duplicated during the cell cycle. Dysregulation of MCM2 has been implicated in various cancers, making it an important target for therapeutic research. MCM2 monoclonal antibodies enable detailed investigation of cell cycle checkpoints and DNA replication mechanisms. Researchers can utilize MCM2 monoclonal antibodies to explore cellular proliferation pathways and identify potential therapeutic targets. Understanding MCM2's role in cancer development has become increasingly significant in oncology research. Santa Cruz Biotechnology monoclonal antibodies for MCM2 continue to support breakthrough discoveries in cancer research and cell biology.